GENECAST's ADPS EGFR Mutation Test Kit used for this clinical study
GENECAST begins clinical research on early diagnosis of lung cancer with Samsung Medical Center
14 juin 2021 05h59 HE | GENECAST
Will it be possible to administer EGFR inhibitors to patients with early-stage non-small cell lung cancer (NSCLC)?The real possibility of the commercial use of liquid biopsies for patients with stage...